| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,003 |
6,471 |
$668K |
| 99199 |
Unlisted special service, procedure or report |
90,451 |
53,818 |
$547K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,161 |
7,217 |
$537K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
703 |
162 |
$166K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,650 |
1,415 |
$149K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,294 |
1,077 |
$120K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,749 |
2,262 |
$103K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,117 |
942 |
$97K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,127 |
9,120 |
$92K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,385 |
2,772 |
$80K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
360 |
332 |
$75K |
| 99442 |
|
1,570 |
1,245 |
$72K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,709 |
4,736 |
$72K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,809 |
3,191 |
$68K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,417 |
2,007 |
$65K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,322 |
3,732 |
$33K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
356 |
297 |
$28K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,469 |
1,081 |
$24K |
| 99401 |
|
698 |
504 |
$22K |
| 92552 |
|
4,274 |
3,622 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
155 |
135 |
$19K |
| 81025 |
|
2,774 |
2,174 |
$17K |
| 81002 |
|
7,379 |
6,063 |
$15K |
| 99051 |
|
702 |
615 |
$15K |
| 87428 |
|
208 |
148 |
$10K |
| 93000 |
|
772 |
637 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
123 |
96 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
205 |
177 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
2,591 |
2,176 |
$6K |
| 96101 |
|
78 |
72 |
$5K |
| D0145 |
Oral evaluation for a patient under three years of age |
108 |
103 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
50 |
36 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
235 |
185 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
256 |
219 |
$3K |
| 0071A |
|
78 |
52 |
$3K |
| 95117 |
|
312 |
124 |
$3K |
| 96127 |
|
585 |
533 |
$2K |
| 0072A |
|
56 |
33 |
$2K |
| 99384 |
|
24 |
13 |
$2K |
| D1206 |
Topical application of fluoride varnish |
110 |
103 |
$2K |
| 99441 |
|
65 |
49 |
$2K |
| 99383 |
|
13 |
12 |
$935.04 |
| 82947 |
|
232 |
173 |
$741.08 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
106 |
49 |
$634.26 |
| 94010 |
|
16 |
13 |
$358.12 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
46 |
38 |
$347.13 |
| 99173 |
|
4,287 |
3,636 |
$307.00 |
| 99070 |
|
47 |
31 |
$250.56 |
| 90686 |
|
274 |
229 |
$57.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
15 |
$1.96 |
| 1111F |
|
115 |
99 |
$0.16 |
| 3044F |
|
26 |
25 |
$0.07 |
| 3080F |
|
165 |
122 |
$0.05 |
| 3077F |
|
201 |
152 |
$0.05 |
| 90651 |
|
385 |
291 |
$0.00 |
| 90619 |
|
340 |
280 |
$0.00 |
| 90696 |
|
36 |
28 |
$0.00 |
| 90656 |
|
49 |
48 |
$0.00 |
| 90744 |
|
32 |
26 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
89 |
59 |
$0.00 |
| 91307 |
|
117 |
68 |
$0.00 |
| 90680 |
|
32 |
29 |
$0.00 |
| 90697 |
|
44 |
33 |
$0.00 |
| 90716 |
|
14 |
13 |
$0.00 |
| 90621 |
|
89 |
69 |
$0.00 |
| 90713 |
|
161 |
148 |
$0.00 |
| 90670 |
|
441 |
356 |
$0.00 |
| 90734 |
|
109 |
82 |
$0.00 |
| 90633 |
|
131 |
115 |
$0.00 |
| 90700 |
|
207 |
193 |
$0.00 |
| 90715 |
|
165 |
132 |
$0.00 |
| 90710 |
|
163 |
134 |
$0.00 |
| 90658 |
|
57 |
39 |
$0.00 |
| 90649 |
|
16 |
15 |
$0.00 |
| 90648 |
|
100 |
95 |
$0.00 |
| 91300 |
|
85 |
73 |
$0.00 |
| 1160F |
|
74 |
67 |
$0.00 |
| 90707 |
|
13 |
12 |
$0.00 |